Oral menopausal hormone therapy (commonly known as hormone replacement therapy or HRT) linked to higher blood clot risk in legs or lungs regardless of dose or duration cross-posted from: https://piefed.world/c/scientificarticles/p/1422114/oral-menopausal-hormone-therapy-commonly-known-as-hormone-replacement-therapy-or-hrt-lin Study. Conversely, stroke and heart attack risks were limited to prolonged use of high-dose oral hormone therapy, while transdermal hormone therapy (delivered via the skin as patches, gels, or sprays) showed no general increased blood clot risk.